Breaking News Instant updates and real-time market news.

FB

Facebook

$182.64

-1.13 (-0.61%)

17:23
04/24/19
04/24
17:23
04/24/19
17:23

Facebook cuts FY19 CapEx view to $17B-$19B from $18B-$20B

Sees FY19 effective tax rate in mid-teens.

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

FB Facebook
$182.64

-1.13 (-0.61%)

04/22/19
CLVD
04/22/19
NO CHANGE
CLVD
Buy
Facebook 2019 estimates raised at Cleveland Research
Cleveland Research analyst Chandler Converse said his checks point to Q1 revenue for Facebook in-line with management's guidance for a mid-single digit deceleration in growth, but he also noted that advertisers seem incrementally more optimistic on the adoption of Stories ads. Additionally, partners appeared to slow plans to diversify budgets away from Facebook in the near-term given better ROI trends, said the analyst, who raised his 2019 estimates and keeps a Buy rating on the stock.
04/22/19
BARD
04/22/19
NO CHANGE
Target $195
BARD
Outperform
Facebook to report in-line to better-than-expected Q1, says Baird
Baird analyst Colin Sebastian expects Facebook to report in-line to better-than-expected Q1 results this week on the back of healthy advertiser demand. Sebastian tells investors in a research note that his firm's checks continue to suggest positive trends for the Facebook ecosystem, adding that Instagram is "particularly strong," despite headline concerns over platform privacy and safety. Management continues to highlight the growing contribution from new channels/formats while Messenger remains an area of increased focus, potentially a highlight at the upcoming F8 conference next week, he says. He maintains an Outperform rating and $195 price target.
04/23/19
FBCO
04/23/19
NO CHANGE
Target $211
FBCO
Outperform
Signs of potential value creation from Facebook new products, says Credit Suisse
Credit Suisse analyst Stephen Ju continues to anticipate the real clearing data point for Facebook shares will arrive on the Q3 report, in which he expects the OpEx/CapEx outlook to signal a return to growth for free cash flow. In the meantime, ahead of Q1 results, his checks continue to suggest minimal deceleration for U.S. budgets coupled with modest headwinds in Europe. Ju also believes there are "greater signs" of potential value creation from new products. The analyst reiterates an Outperform rating on the shares, while raising his price target on the stock to $211 from $210, as he believes Facebook will be able to drive long-term revenue growth without a material lift in ad loads with, the Street models continue to underestimate the long-term monetization potential of other billion-user properties like Messenger and WhatsApp, and free cash flow growth recovery for 2020.
04/24/19
OPCO
04/24/19
NO CHANGE
Target $44
OPCO
Outperform
Twitter price target raised to $44 from $33 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Twitter (TWTR) to $44 from $33 as platform improvements are driving mDAUs and monetization remains strong. The analyst notes that the company's machine learning initiatives have been proactive, flagging 38% of abusive Tweets before being seen. In general, the company has navigated public policy issues better than peers Alphabet (GOOG) and Facebook (FB), he contends. Helfstein reiterates an Outperform rating on Twitter's shares.

TODAY'S FREE FLY STORIES

CLDX

Celldex

$2.53

-0.05 (-1.94%)

, GTXI

GTx

$0.00

(0.00%)

08:12
06/24/19
06/24
08:12
06/24/19
08:12
Hot Stocks
Celldex appoints Diane Young as SVP, CMO »

Celldex Therapeutics…

CLDX

Celldex

$2.53

-0.05 (-1.94%)

GTXI

GTx

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DFRG

Del Frisco's

$6.73

-0.18 (-2.60%)

08:11
06/24/19
06/24
08:11
06/24/19
08:11
Hot Stocks
Breaking Hot Stocks news story on Del Frisco's »

Del Frisco's up 17%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Nov

KRYS

Krystal Biotech

$29.28

0.28 (0.97%)

08:10
06/24/19
06/24
08:10
06/24/19
08:10
Hot Stocks
Krystal Biotech anticipates commencing Phase 3 KB103 trial before year-end »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$29.28

0.28 (0.97%)

08:09
06/24/19
06/24
08:09
06/24/19
08:09
Hot Stocks
Krystal Biotech says safety data shows KB103 was wll-tolerated »

Krystal Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$20.68

-0.135 (-0.65%)

, CVS

CVS Health

$53.68

-0.19 (-0.35%)

08:08
06/24/19
06/24
08:08
06/24/19
08:08
Hot Stocks
Tenet, Aetna announce multi-year agreement »

Tenet (THC) and Aetna, a…

THC

Tenet

$20.68

-0.135 (-0.65%)

CVS

CVS Health

$53.68

-0.19 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RST

Rosetta Stone

$23.23

0.09 (0.39%)

08:06
06/24/19
06/24
08:06
06/24/19
08:06
Conference/Events
Rosetta Stone management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 28

    Jun

PHR

Phreesia

$0.00

(0.00%)

08:05
06/24/19
06/24
08:05
06/24/19
08:05
Syndicate
Phreesia files registration statement for IPO »

Phreesia announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRG

NRG Energy

$35.22

0.2 (0.57%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Upgrade
NRG Energy rating change  »

NRG Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNW

Pinnacle West

$97.60

-0.97 (-0.98%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Conference/Events
Pinnacle West management to meet with Wolfe Research »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

BDSI

BioDelivery Sciences

$4.41

-0.05 (-1.12%)

08:04
06/24/19
06/24
08:04
06/24/19
08:04
Hot Stocks
BioDelivery Sciences expands upon report from Pain Management Task Force »

BioDelivery Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHAS

PhaseBio

$12.52

0.54 (4.51%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Conference/Events
PhaseBio management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

RBB

RBB Bancorp

$19.13

-0.45 (-2.30%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Hot Stocks
RBB Bancorp announces 1M share repurchase program »

RBB Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPL

Texas Pacific Land Trust

$773.00

-21 (-2.64%)

08:02
06/24/19
06/24
08:02
06/24/19
08:02
Hot Stocks
Texas Pacific Land Trust to explore conversion to C-corporation »

Texas Pacific Land Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$114.85

-3.94 (-3.32%)

08:01
06/24/19
06/24
08:01
06/24/19
08:01
Hot Stocks
Royal Caribbean, ITM Group partner to form new destination company »

Royal Caribbean and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTYH

GTY Technology Holdings

$7.64

-0.26 (-3.29%)

08:01
06/24/19
06/24
08:01
06/24/19
08:01
Hot Stocks
GTY Technology Holdings announces cooperative contract with Texas DIR »

GTY Technology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$74.34

0.94 (1.28%)

07:59
06/24/19
06/24
07:59
06/24/19
07:59
Hot Stocks
Alnylam presents new ONPATTRO results at 2019 PNS meeting »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMSY

HMS Holdings

$31.86

-0.71 (-2.18%)

, UNH

UnitedHealth

$252.31

4.53 (1.83%)

07:57
06/24/19
06/24
07:57
06/24/19
07:57
Recommendations
HMS Holdings, UnitedHealth analyst commentary  »

HMS Holdings' recent…

HMSY

HMS Holdings

$31.86

-0.71 (-2.18%)

UNH

UnitedHealth

$252.31

4.53 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 18

    Jul

CZR

Caesars

$9.99

-0.05 (-0.50%)

, ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

07:56
06/24/19
06/24
07:56
06/24/19
07:56
Hot Stocks
Caesars to adjourn Annual Meeting of shareholders »

Caesars Entertainment…

CZR

Caesars

$9.99

-0.05 (-0.50%)

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

TTPH

Tetraphase

$0.63

-0.02 (-3.10%)

07:56
06/24/19
06/24
07:56
06/24/19
07:56
Hot Stocks
Tetraphase presents new Xerava data at ASM »

Tetraphase announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNCE

Concert Pharmaceuticals

$10.90

-0.165 (-1.49%)

07:53
06/24/19
06/24
07:53
06/24/19
07:53
Initiation
Concert Pharmaceuticals initiated  »

SunTrust starts Concert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

WAB

Wabtec

$72.75

0.42 (0.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Downgrade
Wabtec rating change  »

Wabtec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SHSP

SharpSpring

$12.84

-0.34 (-2.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Upgrade
SharpSpring rating change  »

SharpSpring upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$85.58

2.55 (3.07%)

07:50
06/24/19
06/24
07:50
06/24/19
07:50
Downgrade
CarMax rating change  »

CarMax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Sep

BARZ

5Barz

$0.00

(0.00%)

07:49
06/24/19
06/24
07:49
06/24/19
07:49
Hot Stocks
5Barz signs agreement with Kaynes Technology for Network Extender in India »

5BARz International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAMP

LiveRamp

$51.13

-1.135 (-2.17%)

07:47
06/24/19
06/24
07:47
06/24/19
07:47
Earnings
LiveRamp raises FY20 revenue view to $363M-$377M from $358M-$372M »

Consensus $366.45M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.